Literature DB >> 9817170

Expression of three members of the TNF-R family of receptors (4-1BB, lymphotoxin-beta receptor, and Fas) in human lung.

V Boussaud1, P Soler, J Moreau, R G Goodwin, A J Hance.   

Abstract

Receptors belonging to the tumour necrosis factor receptor (TNF-R) superfamily are implicated in a variety of important biological processes. Although messenger ribonucleic acid coding for many of these receptors has been detected in lung, little is known about their expression in this organ. In this study, immunohistochemical techniques were used to evaluate the expression of three receptors of this family (4-1BB, lymphotoxin-beta receptor (LTbeta-R), and Fas) in normal human lung, lung carcinomas and by tuberculous and sarcoid granulomas. The 4-1BB receptor was uniformly expressed by endothelial cells of small vessels and by basal epithelial cells within pseudostratified bronchial epithelium. LTbeta-R expression by parenchymal cells was limited to those of epithelial origin (bronchial and bronchiolar epithelium, hyperplastic alveolar epithelium and lung carcinomas). Fas was present on both fibroblasts and epithelial cells (bronchial and alveolar epithelium and most, but not all, carcinomas), but not on endothelial cells. A subpopulation of T-lymphocytes expressed these receptors, but only Fas was detected on normal alveolar macrophages and epithelioid cells. Thus, 4-1BB, LTbeta-R, and Fas have characteristic and only partially overlapping patterns of expression in the lung. The findings should facilitate further evaluation of their role in lung homeostasis and pathology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817170     DOI: 10.1183/09031936.98.12040926

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling.

Authors:  Taylor A Doherty; Pejman Soroosh; Naseem Khorram; Satoshi Fukuyama; Peter Rosenthal; Jae Youn Cho; Paula S Norris; Heonsik Choi; Stefanie Scheu; Klaus Pfeffer; Bruce L Zuraw; Carl F Ware; David H Broide; Michael Croft
Journal:  Nat Med       Date:  2011-04-17       Impact factor: 53.440

2.  Regulation of mouse 4-1BB expression: multiple promoter usages and a splice variant.

Authors:  Jung D Kim; Chang H Kim; Byoung S Kwon
Journal:  Mol Cells       Date:  2011-01-11       Impact factor: 5.034

3.  Fas/Fas ligand system mediates epithelial injury, but not pulmonary host defenses, in response to inhaled bacteria.

Authors:  G Matute-Bello; C W Frevert; W C Liles; M Nakamura; J T Ruzinski; K Ballman; V A Wong; C Vathanaprida; T R Martin
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

4.  Role of 4-1BB receptor in the control played by CD8(+) T cells on IFN-gamma production by Mycobacterium tuberculosis antigen-specific CD4(+) T Cells.

Authors:  Carla Palma; Silvia Vendetti; Antonio Cassone
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

Review 5.  Anti-CD137 antibodies in the treatment of autoimmune disease and cancer.

Authors:  Robert S Mittler; Juergen Foell; Megan McCausland; Simona Strahotin; Liguo Niu; Abhijit Bapat; L Becker Hewes
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 6.  Alveolar epithelial type II cell: defender of the alveolus revisited.

Authors:  H Fehrenbach
Journal:  Respir Res       Date:  2001-01-15

7.  Cell surface marker profiling of human tracheal basal cells reveals distinct subpopulations, identifies MST1/MSP as a mitogenic signal, and identifies new biomarkers for lung squamous cell carcinomas.

Authors:  Emily Van de Laar; Monica Clifford; Stefan Hasenoeder; Bo Ram Kim; Dennis Wang; Sharon Lee; Josh Paterson; Nancy M Vu; Thomas K Waddell; Shaf Keshavjee; Ming-Sound Tsao; Laurie Ailles; Nadeem Moghal
Journal:  Respir Res       Date:  2014-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.